By Hannah Green The Cambridge company behind the technology that enabled the first-ever pig-to-human kidney transplant earlier this year has raised a mega-round of funding. The biotech eGenesis said on Wednesday that it has closed a $191 million Series D financing led by Lux Capital. Existing investors including Arch Ventures and Leaps by Bayer, as well new investors, also […]
By Greg Ryan A Boston-based real estate developer is proposing a 12-story, 227-unit residential building in Alewife, the Cambridge neighborhood that was put under a construction moratorium for more than a year out of fear it would be overrun by life sciences labs. Boylston Properties is hosting community meetings next week to discuss its plans to […]
By Greg Ryan CBRE Group Inc.’s investment arm has sold a shopping plaza in Cambridge’s Porter Square to two local firms for $20.1 million. Crosspoint Associates and Long Wharf Capital now own Porter Square Galleria, a 55,610-square-foot property anchored by a Target Corp. store. The plaza is 96% leased, with Retro Fitness, Citizens Bank and Anna’s Taqueria among its other […]
By Sam Doran and Sam Drysdale, State House News Service After years of debate, lawmakers finally came to an agreement to expand the number of alcohol licenses in Boston. There are 225 new licenses authorized in a compromise bill filed by House and Senate negotiators Tuesday afternoon, including 195 “restricted” licenses specifically marked for neighborhoods […]
The Biosecure Act could ban Chinese biotechs and hurt Mass. drug developers. But some see an opportunity for local R&D.By Hannah Green Driven by concerns over national security, the federal government is weighing a crackdown on Chinese biotechnology suppliers that would have far-reaching effects in the life sciences industry. The legislation, known as the Biosecure Act, would prevent biotech […]
By JLL In the past 12 months, Boston has emerged as the top major market in the United States for workers returning to the office. According to foot traffic data from Placer.AI, office attendance in Boston has increased by 10.3% during this period, marking a significant improvement from a year ago when the city lagged in […]
By Jon Chesto When demand for office space cratered during the COVID-19 pandemic, many developersdoubled down on building lab space instead. Lately, it sure seems like they went overboard. With newly builtlife sciences buildings hitting the market at a much faster rate than they can be filled, the availability of lab space in Greater Boston […]
By Greg Ryan The downtown Boston office market has captured the lion’s share of local attention — and alarm — since Covid-19 upended the five-day, in-office workweek. But now there’s cause for concern across the Charles River for the 12 million square feet of offices in Cambridge. A CBRE report this month found that, for the first time since the […]
By Greg Ryan Five years ago, nearly half of the region’s lab space was in Cambridge, according to CBRE research. Today, about a third is. But a life sciences facility is not a “Field of Dreams.” Just because developers built labs in new places does not mean the biotechs will come — at least in this real estate market. […]
By Greg Ryan A unit of the German software maker SAP is subleasing a floor of office space at 60 State St. in downtown Boston, nearly doubling its footprint at its Watertown location. SAP LeanIX (NYSE: SAP) is taking about 25,000 square feet from LinkSquares at the Boston office tower, with plans to move into the […]
